The Latest Breaking News from FDA

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease. The FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticized…

The FDA on Friday authorized the use of the Alzheimer’s drug lecanemab, the first drug clearly shown to slow the progress of the debilitating brain disease.

Numerous companies at CES 2023 have jumped into the potentially lucrative market for over-the-counter hearing aids.

Walgreens and CVS can now sell the abortion pill — but will they?

Social media users shared a range of false claims this week

Biogen stock jumped late Friday after the Food and Drug Administration approved its second Alzheimer's treatment, now called Leqembi.

There's a large pipeline of promising yet expensive drugs that could get approved.

Once certified, the two largest national pharmacy chains will be able to prescribe mifepristone, a pill used in medication abortions.

Changes by the FDA mean patients won't have to schedule in-person exams to get a prescription. That opens the door for more pharmacies to provide the medication. But not everyone will have access.